Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BEta Blocker dEprescription Following Coronary Artery Bypass Graft sURGERy: Feasibility and Safety Pilot (BEEFBURGER Trial)

NCT04788186 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT04788186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04788186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BEta Blocker dEprescription Following Coronary Artery Bypass Graft sURGERy: Feasibility and Safety Pilot (BEEFBURGER Trial)
Lead sponsor
University of Saskatchewan
Phase
Phase 4
Overall status
Unknown status
Start date
August 23, 2021
Completion date
August 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, coronary artery disease, coronary artery stenosis, non-st elevation myocardial infarction (nstemi), st elevation myocardial infarction